Cortexyme, Inc. Uncategorized Contracts & Agreements
8 Contracts & Agreements
- Offer Letter between Quince Therapeutics, Inc. and Charles Ryan, dated as of August 1, 2023 (Filed With SEC on November 14, 2023)
- Open Market Sale AgreementSM dated December 23, 2021, by and between Cortexyme, Inc. and Jefferies LLC (Filed With SEC on December 23, 2021)
- Third Amendment to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated July 15, 2021 (Filed With SEC on August 6, 2021)
- Description of Securities (Filed With SEC on March 1, 2021)
- Second Amendment to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated May 26, 2020 (Filed With SEC on August 14, 2020)
- Description of Securities (Filed With SEC on March 16, 2020)
- Amendment No. 1 to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated April 2, 2019 (Filed With SEC on August 9, 2019)
- Sub-Sublease Agreement by and between Cortexyme, Inc. and Verily Life Sciences LLC, dated June 18, 2018 (Filed With SEC on April 12, 2019)
